| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,801 |
1,290 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,363 |
1,786 |
$86K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
858 |
625 |
$67K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,849 |
1,193 |
$65K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,302 |
1,003 |
$57K |
| 99000 |
|
2,015 |
1,597 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
575 |
420 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
87 |
85 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
280 |
229 |
$4K |
| 87428 |
|
51 |
47 |
$3K |
| 81002 |
|
419 |
327 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36 |
31 |
$740.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
126 |
85 |
$239.62 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
55 |
40 |
$144.91 |